90% CI limbo [General Sta­tis­tics]

posted by VStus – Poland, 2017-03-01 15:07 (3390 d 18:21 ago) – Posting: # 17116
Views: 23,590

Dear Helmut,
Dear all,

I have limited data about partial replicate trial (2x3x3) with RSABE, which I want to use to assess the feasibility of same study under EMA regulation (assuming that EU has the same Reference product as US).

Reported parameters:
Number of subjects (observations per treatment arm)
Swr estimated using PROC GLM
Point Estimate (%) from RSABE-approach
95% CI upper confidence bound

Is it feasible to try calculation of 90% CIs?

Can I apply the formula below?

90% CI = log(Point_Estimate) +/- Swr * qt(0.05, df))*100,

where:
df=2*n-3 for partial replicate (2x3x3);
df=3*n-4 for full replicate (2x2x4);

Thank you very much in advance!

Regards, VStus

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
98 visitors (0 registered, 98 guests [including 26 identified bots]).
Forum time: 10:28 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5